Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 195   

Articles published

VRX 15.33 -0.30 (-1.92%)
price chart
Valeant Pharmaceuticals International Inc to sell US$2.1 billion in assets to ...
Valeant Pharmaceuticals International Inc., the embattled Canadian drugmaker, agreed to sell about US$2.1 billion in assets to get cash to streamline its businesses and begin easing its debt burden.
Valeant Pharmaceuticals Intl Inc. Just Sold Over US$2 Billion in Assets ...  The Motley Fool Canada
Valeant Pharmaceuticals sells 3 of its products to L'Oreal  Globalnews.ca
Valeant Pharmaceuticals Intl Inc. on Fire to Start the Year
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has made plenty of moves to lighten its debt load, while advancing some of its key treatments heading into 2017.
Valeant Pharmaceuticals Intl Inc (VRX) Stock Rating Reaffirmed by Scotiabank  Sports Perspectives
Featured Stock Overview: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)  FactsReporter
On the Move! Valeant Pharmaceuticals Intl Inc. Rises Again
Just when you thought there could be no more drama with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), the company comes through with a massive announcement.
Valeant Pharmaceuticals International, Inc. (VRX) Stock Rating Reaffirmed by ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSE:VRX)'s stock had its “hold” rating restated by equities research analysts at Canaccord Genuity in a research report issued to clients and investors on Thursday.
Valeant Pharmaceuticals International, Inc. (VRX) Receives Average ...  The Cerbat Gem
Valeant Pharmaceuticals Intl Inc (VRX) Earns "Sector Perform" ...  Community Financial News
Valeant Pharmaceuticals Intl Inc.: Stay on the Sidelines
But when it comes to Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), my advice is to sit on the sidelines. Valeant didn't ever deserve to trade at $335, and it is highly unlikely it will ever experience that again.
Piper Jaffray Cos. Analysts Give Valeant Pharmaceuticals International Inc ...  Sports Perspectives
Revenue Estimates Analysis: Valeant Pharmaceuticals International, Inc ...  News Oracle
Why Valeant Pharmaceuticals Intl Inc. Will Fail to Re-Invent Itself
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had an abysmal year as the stock plummeted 86%. The company wants to re-invent itself to become a dominant player in the pharmaceutical scene again.
Analytical Overview of Valeant Pharmaceuticals International, Inc. (NYSE:VRX)  FactsReporter
Valeant Pharmaceuticals International, Inc. (NYSE:VRX): A Stock to Avoid  Smаrt Stоck Nеws
Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For ...
LAVAL, Quebec, Jan. 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, ...
Valeant Pharmaceuticals gets breathing room, but little else from selling off ...
After months of promises and rumors of asset sales that went unrealized, Valeant Pharmaceuticals International Inc. finally answered doubters and creditors on Tuesday, announcing it was selling skin-care brands to L'Oreal SA for US$1.3 billion and its ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Would no Longer be Able to Sell ...
Canadian pharmaceutical giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been keen to sell its business assets lately, while the recent development is not quite promising.
Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its ...
LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter to serve as a director, effective January ...